Valneva SE Logo

Valneva SE

Specialty vaccine company developing and commercializing vaccines for infectious diseases.

VLA | PA

Overview

Corporate Details

ISIN(s):
AT0000A10B99 (+3 more)
LEI:
969500DIVIP5VKNW4948
Country:
France
Address:
6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN

Description

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-08-04 07:00
Valneva Reports H1 Results Marked by Major Corporate Achievements and Strong Ca…
English 712.7 KB
2020-07-22 18:45
Valneva annonce des résultats initiaux positifs pour l’étude de Phase 2 de son …
French 870.1 KB
2020-07-22 18:45
Valneva Announces Positive Initial Results for Phase 2 Study of Lyme Disease Va…
English 599.9 KB
2020-07-20 07:00
Valneva Confirms Participation in UK Government COVID-19 Vaccine Response Progr…
English 311.0 KB
2020-07-20 07:00
Valneva confirme sa participation au programme de réponse vaccinale au COVID-19…
French 434.1 KB
2020-07-10 10:32
Franchissement de seuils
French 407.7 KB
2020-07-07 18:00
Bilan Semestriel du contrat de liquidité de Valneva SE
French 7.0 KB
2020-07-07 18:00
Valneva - Déclaration d’actions et de droits de vote – JUIN 2020
English 206.5 KB
2020-06-18 07:19
Valneva and Bavarian Nordic Announce Marketing and Distribution Partnership
English 241.8 KB
2020-06-18 07:19
Valneva et Bavarian Nordic annoncent un partenariat pour le marketing et la dis…
French 285.2 KB
2020-06-17 18:15
Valneva Announces Successful Outcome of its AGM and the Appointment of two new …
English 311.9 KB
2020-06-17 18:15
Valneva annonce le succès de son Assemblée Générale et la nomination de deux no…
French 317.6 KB
2020-05-07 07:00
Valneva Reports Q1 Results and Updates 2020 Guidance Following Major Lyme Partn…
English 883.6 KB
2020-02-27 07:00
Valneva annonce des ventes record et des avancées R&D importantes en 2019
French 904.5 KB
2020-02-27 07:00
Valneva Reports Record Product Sales and Major Pipeline Progress in 2019
English 718.8 KB

Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Valneva SE

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Valneva SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-03-18 N/A Other Buy 44,222 N/A
2024-01-03 N/A Other Other 34,802 N/A
2023-06-20 N/A Other Sell 192,547 1,406,228.50 EUR
2023-06-19 N/A Other Sell 30,661 209,629.26 EUR
2023-06-16 N/A Other Sell 85,589 582,493.06 EUR
2023-06-15 N/A Other Sell 28,179 189,503.78 EUR
2023-06-14 N/A Other Sell 228,951 1,519,914.11 EUR
2023-06-13 N/A Other Sell 29,401 187,922.37 EUR
2023-06-12 N/A Other Sell 117,854 733,782.57 EUR
2023-05-10 N/A Other Buy 87,523 N/A

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.